• Neurothera Labs to consolidate shares 1-for-14, lifting the trading price and supporting minimum-price thresholds for a potential U.S. listing.
• Consolidated trading expected to start around Sept. 2, 2026 on the TSX Venture Exchange under NTLX.
• Shares outstanding expected to fall to about 13,724,464 from 192,142,499, subject to rounding and any pre-consolidation issuance.
• Fractional shares will not be issued; entitlements will be rounded up to the nearest whole share.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurothera Labs Inc. published the original content used to generate this news brief via TheNewswire (Ref. ID: 202608281705TNWSWRCACNPR_____1B2aFNwjo) on August 28, 2026, and is solely responsible for the information contained therein.